个性化文献订阅>期刊> EMBO journal
 

Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis

  作者 Schwandt, T; Schumak, B; Gielen, GH; Jungerkes, F; Schmidbauer, P; Klocke, K; Staratschek-Jox, A; van Rooijen, N; Kraal, G; Ludwig-Portugall, I; Franken, L; Wehner, S; Kalff, JC; Weber, O; Kirschning, C; Coch, C; Kalinke, U; Wenzel, J; Kurts, C; Zawatzky, R; Holzmann, B; Layland, L; Schultze, JL; Burgdorf, S; den Haan, JMM; Knolle, PA; Limmer, A  
  选自 期刊  EMBO journal;  卷期  2012年31-1;  页码  201-213  
  关联知识点  
 

[摘要]Early during Gram-negative sepsis, excessive release of pro-inflammatory cytokines can cause septic shock that is often followed by a state of immune paralysis characterized by the failure to mount adaptive immunity towards secondary microbial infections. Especially, the early mechanisms responsible for such immune hypo-responsiveness are unclear. Here, we show that TLR4 is the key immune sensing receptor to initiate paralysis of T-cell immunity after bacterial sepsis. Downstream of TLR4, signalling through TRIF but not MyD88 impaired the development of specific T-cell immunity against secondary infections. We identified type I interferon (IFN) released from splenic macrophages as the critical factor causing T-cell immune paralysis. Early during sepsis, type I IFN acted selectively on dendritic cells (DCs) by impairing antigen presentation and secretion of pro-inflammatory cytokines. Our results reveal a novel immune regulatory role for type I IFN in the initiation of septic immune paralysis, which is distinct from its well-known immune stimulatory effects. Moreover, we identify potential molecular targets for therapeutic intervention to overcome impairment of T-cell immunity after sepsis. The EMBO Journal (2012) 31, 201-213. doi: 10.1038/emboj.2011.380; Published online 28 October 2011

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内